Oxylabs 的估值已达到 36 亿美元，使其成为立陶宛第二大最有价值的私营公司。这一重要的融资轮次凸显了对欧洲科技初创公司日益增长的投资，尤其是在 AI 领域。 AI
影响 凸显了对欧洲 AI 基础设施和服务的强劲投资。
排序理由 一家非前沿 AI 公司的重要融资轮次，确立了其估值和市场地位。
在 Mastodon — sigmoid.social 阅读 →
AI 生成摘要 · Google Gemini · 来自 2 个来源。 我们如何撰写摘要 →
Oxylabs 估值达 36 亿美元，成为立陶宛第二大最有价值的私营公司 · 跟踪 2 个来源
报道来源 [2]
-
Oxylabs becomes Lithuania’s second most valuable private company at $3.6B — TFN https://www. byteseu.com/2182746/ # AI # Europe # funding # Lithuania # News # s
Oxylabs becomes Lithuania’s second most valuable private company at $3.6B — TFN https://www. byteseu.com/2182746/ # AI # Europe # funding # Lithuania # News # startups
-
https://www. europesays.com/3120742/ Oxylabs becomes Lithuania’s second most valuable private company at $3.6B — TFN # AI # Europe # funding # Lietuva # lithuan
https://www. europesays.com/3120742/ Oxylabs becomes Lithuania’s second most valuable private company at $3.6B — TFN # AI # Europe # funding # Lietuva # lithuania # naujienos # News # startups